Linked Life Data

1841830

Source:http://linkedlifedata.com/resource/pubmed/id/1841830

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3-4
pubmed:dateCreated
1992-12-3
pubmed:abstractText
Immunodeficiency, particularly antibody deficiency, is a crucial contributory factor to the increased susceptibility to infections in preterm infants. Availability of the recent preparation of intravenous immunoglobulin (ivIgG) led several authors to evaluate the safety and effectiveness of ivIgG for prophylaxis of infection in preterm infants. The results of these studies, although controversial, have pointed out two common findings: (1) ivIgG prophylaxis seems to be effective only in the very preterm infants, with mean birth weight below about 1,300 g: (2) ivIgG seems to be well tolerated by newborn infants.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0379-8305
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
144-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Intravenous immunoglobulin for prophylaxis of infection in preterm infants.
pubmed:affiliation
Division of Neonatal Intensive Care, Policlinico San Matteo IRCCS, Pavia, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Review